Clinical trial
A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics
NCT02960490 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 26, 2016
- Completion date
- November 25, 2019
- Enrollment
- 66 (actual)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis